Status:
RECRUITING
Combined Photo-Biomodulation At Acupuncture Points, Autologous PRP, and Umbilical Cord-Derived Exosome Therapy in Autism Spectrum Disorder
Lead Sponsor:
Iffat Anwar Medical Complex
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
3-12 years
Phase:
NA
Brief Summary
This randomized controlled trial aims to evaluate the efficacy of a combination of photo-biomodulation at acupuncture points, autologous platelet-rich plasma (PRP), and umbilical cord-derived exosome ...
Detailed Description
The study involves three main interventions: 1. Photo-Biomodulation (PBM): PBM will be performed once a week using an 810nm, 210mW laser probe for 20 seconds at each selected acupuncture point. 2. Au...
Eligibility Criteria
Inclusion
- • Diagnosis of Autism Spectrum Disorder based on DSM-5 criteria
- Age 3-12 years
- Stable on current medications for at least 4 weeks prior to study entry
- Parents or legal guardians willing to provide informed consent
Exclusion
- • Severe comorbid medical conditions
- Prior stem cell or exosome therapy
- History of hypersensitivity to any component of the interventions
- Inability to comply with study procedures
Key Trial Info
Start Date :
August 13 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 13 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06600529
Start Date
August 13 2024
End Date
December 13 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iffat Anwar Medical Complex
Lahore, Punjab Province, Pakistan, 54000